Healthcare -
Biotechnology - NASDAQ - US
$ 37.25
-0.268 %
$ 5.85 B
Market Cap
248.33
P/E
TGTX - NET INCOME
Net Income TGTX - TG Therapeutics, Inc.
23.4 M
LAST VALUE
45.53%
2 YEAR CAGR
16.38%
5 YEAR CAGR
9.24%
10 YEAR CAGR